已收盘 07-02 16:00:00 美东时间
+0.080
+1.52%
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Monday. Shares of Apogee Therapeutics Inc (NASDAQ:APGE) rose sharply on Monday. AbbVie Inc. (NYSE:ABBV) announced Monday that it has agreed to acquire Apogee Therapeutics in a cash deal valued at approximately $10.9 bi...
06-23 00:08
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it has entered into securities purchase agreements with a single h...
06-18 01:17
IceCure Medical Ltd. (NASDAQ:ICCM) shares are soaring Wednesday after the company reported a 70% jump in its U.S. commercial install base for ProSense, its breast cancer cryoablation system. Here’s what you should know. IceCure Medical stock is showing exceptional strength. What’s fueling ICCM momen...
06-18 00:45
Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Significant rise in number of leads for ProSense® systems generated at U.S. medical society conferences compared to last year ProSense® breast cancer cryoablation procedures have been performed in major cit...
06-17 20:28
U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-market trading: BVC, TLK, INDP, APPN, WIX, KB, SSSS, IPSC, AMPL, ICCM, SBSW, ROMA.
06-08 20:04
IceCure Medical shares are trading lower after the company announced a 1-for-30...
06-02 21:23
Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets StrategyCAESAREA, ISRAEL, June 2, 2026 /PRNewswire/ -- IceCure Medical Ltd. (the "Company" or "IceCure" or "IceCure Medical")
06-02 20:43
Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday...
05-20 05:06
At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors ≤3 cm and 83.9% of patients remained recurrence-free at a median
05-19 20:41
今日重点评级关注:HC Wainwright & Co.:维持Autolus Therapeutics"买入"评级,目标价从9美元升至10美元;Maxim Group:维持Rezolute"买入"评级,目标价从4美元升至10美元
05-15 10:49